China-Swiss Investment and Cooperation Forum

Swiss financial group, Cedrus Group in collaboration with Beijing’s Municipal Government and the city's largest districts for pharmaceutical investment, proudly present the inaugural China-Swiss Investment and Cooperation Forum. This event celebrates 75 years of China-Swiss bilateral relations, aiming to deepen cooperation between the Swiss and Chinese life sciences communities.

The Forum is ideal for innovative Swiss biotech companies and founders seeking:

1. Access to investors, including venture capital funds, family offices, and sovereign wealth funds from China, the Middle East, and Europe
2. Connectivity with potential strategic partners, including the largest pharmaceutical companies in China, for investment, manufacturing, and distribution
3. Regulatory guidance on entering China from the Chinese FDA (National Medical Products Administration)
4. Specialized insights on government policies and incentives
5. Partnering opportunities for drug development and clinical trials

Featuring panel discussions, top-level government speakers, company presentations, and site visits, the Forum offers comprehensive industry insights and a gateway to connect and grow in the Greater China Region. Participants will have the opportunity to sign up for one-on-one partnering sessions with company management teams, investors, and strategic players to help achieve their goals.